Millennium Management’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100,000
Closed -$416K 6404
2024
Q3
$416K Buy
100,000
+24,600
+33% +$129K ﹤0.01% 4973
2024
Q2
$412K Buy
+75,400
New +$601K ﹤0.01% 4717
2024
Q1
Sell
-425,200
Closed -$1.73M 6583
2023
Q4
$1.73M Buy
+425,200
New +$1.57M ﹤0.01% 3723

Other funds holding SANA

Millennium Management's SANA Position: Q1 2026 in Review

Millennium Management increased its Sana Biotechnology (SANA) stake by 155% in Q1 2026, buying an estimated $3.81M and bringing the position to 1,591,030 shares worth $4.58M. The position accounts for ﹤0.01% of the portfolio, ranked #3047.

Millennium Management first reported a position in SANA in Q4 2021 and has held it in 17 quarters since. The position peaked at $8.96M in Q4 2023. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Millennium Management held 1,591,030 shares of Sana Biotechnology worth $4.58M as of Q1 2026.
  • Millennium Management bought 967,788 Sana Biotechnology shares in Q1 2026, an estimated $3.81M.
  • Sana Biotechnology made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3047 holding.
  • Millennium Management first reported a position in Sana Biotechnology in Q4 2021 and has held it in 17 quarters since.
  • Millennium Management's Sana Biotechnology position peaked at $8.96M in Q4 2023.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.